AGPUHIGH SIGNALFINANCIAL10-K

AGPU underwent a massive financial transformation with net losses exploding to -$233.1M while simultaneously raising significant capital that boosted stockholders' equity from negative $203K to $47.7M.

This dramatic swing suggests AGPU completed a major capital raise or business combination that injected substantial funds but came with enormous associated costs or write-downs. The 1,740% increase in net losses alongside the equity boost indicates either massive one-time charges, acquisition costs, or operational scaling that investors need to understand immediately.

Comparing 2026-03-31 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

AGPU's financials show a company that simultaneously raised massive capital (stockholders' equity jumped 23,651% to $47.7M, cash increased 1,369% to $10.8M) while experiencing catastrophic losses that increased 1,741% to -$233.1M. R&D spending exploded 8,163% to $2.1M and operating losses widened dramatically to -$180.9M, while revenue only grew modestly by 43% to $655K. This suggests either a major business combination with substantial associated costs/write-downs or aggressive scaling that came with enormous one-time charges, creating a complex situation where the company is simultaneously better capitalized yet posting massive losses.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+23651.1%
-$203K$47.7M

Equity base grew 23651.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

R&D Expense
P&L
+8162.7%
$26K$2.1M

R&D investment increased 8162.7% — signals commitment to future product development, though near-term margin impact.

Current Assets
Balance Sheet
+1821.5%
$2.2M$42.8M

Current assets grew 1821.5% — improving short-term liquidity or inventory/receivables build.

Net Income
P&L
-1740.6%
-$12.7M-$233.1M

Net income declined 1740.6% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-1553.8%
-$10.9M-$180.9M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Cash & Equivalents
Balance Sheet
+1368.8%
$735K$10.8M

Cash position surged 1368.8% — strong cash generation or capital raise providing significant financial cushion.

Total Assets
Balance Sheet
+963.6%
$5.0M$52.9M

Asset base grew 963.6% — expansion through organic growth, acquisitions, or capital deployment.

Interest Expense
P&L
-100%
$391K3

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Accounts Receivable
Balance Sheet
-95.7%
$746K$32K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Revenue
P&L
+43.4%
$456K$655K

Strong top-line growth of 43.4% — accelerating demand or successful expansion into new markets.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-31
ADDED
poai20251231_10k.htm FY 2025 --12-31 false 0001446159 2 2 0 0 0 0 0 5 5 10 3 5 5 5 5 5 0 10 10 0 0 0 15 0.01 0.01 0.01 0.01 false false false false The Senior Director of IT and Cybersecurity, in coordination with our executive officers, work collaboratively across the Company to implement a program designed to protect the Company s information systems from cybersecurity threats and to promptly respond to any cybersecurity incidents in accordance with the Company s incident response plan.
To facilitate the Company s cybersecurity risk management program, the Company s internal IT team is deployed to work with business functions across the Company to address cybersecurity threats and to respond to cybersecurity incidents.
The Senior Director of IT and Cybersecurity, as leader of the internal IT team, monitors the prevention, detection, mitigation, and remediation of cybersecurity threats and incidents in real time, and reports such threats and incidents to the executive officers and Board when appropriate.
The Board oversees the Company s ERM process, including the management of risks arising from cybersecurity threats.
The Board receives reports on cybersecurity risks, which address a wide range of topics including recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, technological trends, and information security considerations arising with respect to the Company s peers and third parties.
+7 more — sign up free →
REMOVED
As of June 28, 2024, the last business day of the registrant s most recently completed second fiscal quarter, the aggregate market value of common stock held by non-affiliates was $ 5,819,537 based upon 5,595,709 shares at $1.04 per share as reported on the NASDAQ Capital Market.
As of March 26, 2025, the registrant had 8,931,621 shares of common stock, par value $.01 per share, outstanding.
The following summarizes the principal risks of our business: There is substantial doubt about our ability to continue as a going concern without additional financing; Risks relating to our plans regarding a merger with Renovaro, Inc.
General References in this annual report on Form 10-K to Predictive , Company , we , us , and our refer to the business of Predictive Oncology Inc.
Overview We are a knowledge and science-driven company that applies artificial intelligence ( AI ) to support the discovery and development of optimal cancer therapies, which can ultimately lead to more effective treatments and improved patient outcomes.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →